Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study
Abstract Background Expanded access programs (EAPs) allow patients with serious, life-threatening conditions access to drugs prior to their formal approval. Despite the possible benefits for patients, EAPs present several challenges, including uncertainty regarding a drug’s efficacy and safety as we...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Orphanet Journal of Rare Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13023-020-01477-7 |
id |
doaj-a86e3ffe192e40ca8e4ae08a520c7320 |
---|---|
record_format |
Article |
spelling |
doaj-a86e3ffe192e40ca8e4ae08a520c73202020-11-25T03:18:49ZengBMCOrphanet Journal of Rare Diseases1750-11722020-07-011511910.1186/s13023-020-01477-7Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative studyPetra Kiefer0Janbernd Kirschner1Astrid Pechmann2Thorsten Langer3Department of Neuropediatrics and Muscle Disorders, Center for Pediatrics, Faculty of Medicine, University of FreiburgDepartment of Neuropediatrics and Muscle Disorders, Center for Pediatrics, Faculty of Medicine, University of FreiburgDepartment of Neuropediatrics and Muscle Disorders, Center for Pediatrics, Faculty of Medicine, University of FreiburgDepartment of Neuropediatrics and Muscle Disorders, Center for Pediatrics, Faculty of Medicine, University of FreiburgAbstract Background Expanded access programs (EAPs) allow patients with serious, life-threatening conditions access to drugs prior to their formal approval. Despite the possible benefits for patients, EAPs present several challenges, including uncertainty regarding a drug’s efficacy and safety as well as inequities regarding access to treatment. Although the number of EAPs is growing, the experience of patients participating in EAPs has not yet been studied. In Germany, an EAP for the treatment of Spinal Muscular Atrophy (SMA) with nusinersen ran from December 2016 to May 2017). SMA is a rare, progressive neuromuscular disorder characterized by muscle atrophy and proximal muscle weakness. Insights into patients’ and caregivers’ experiences could help to improve future EAPs. Results We conducted a prospective study using semi-structured interviews with caregivers of children with Spinal Muscular Atrophy (SMA) Type 1who participated in the nusinersen EAP in Germany. Interviews were transcribed verbatim and analyzed using an inductive approach according to the principles of content analysis. Eight families participated in the study. Their children were between 2 and 28 months old. Six children received non-invasive ventilation. Participation in the EAP marked an important turning point in the caregivers’ experiences. Their perspective changed from a severely limited life expectancy and a palliative approach to a more optimistic view including hopes for a longer life and positive development of their children. However, participating in the EAP was also challenging for caregivers in several ways. Lack of information regarding the launch of the program and the enrollment procedures caused significant uncertainty and stress among caregivers prior to the actual treatment. Further, concerns persisted that nusinersen could not be approved or that the child could be excluded due to an insufficient treatment response. Good communication and trusting relationships with medical and non-medical staff at the hospital helped caregivers cope with the uncertainties associated with the treatment. Conclusion From the caregivers’ perspective, there was no alternative to participating in the EAP for nusinersen. All participants were positive regarding their decision to participate. However, this study suggests that developing procedures to increase speed and transparency and to ensure fairness could help to further improve the system of EAPs as a way to provide urgently needed care to highly vulnerable patients.http://link.springer.com/article/10.1186/s13023-020-01477-7Spinal muscular atrophyNusinersenExpanded Access programCompassionate care programQualitative researchInterview study |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Petra Kiefer Janbernd Kirschner Astrid Pechmann Thorsten Langer |
spellingShingle |
Petra Kiefer Janbernd Kirschner Astrid Pechmann Thorsten Langer Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study Orphanet Journal of Rare Diseases Spinal muscular atrophy Nusinersen Expanded Access program Compassionate care program Qualitative research Interview study |
author_facet |
Petra Kiefer Janbernd Kirschner Astrid Pechmann Thorsten Langer |
author_sort |
Petra Kiefer |
title |
Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study |
title_short |
Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study |
title_full |
Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study |
title_fullStr |
Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study |
title_full_unstemmed |
Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study |
title_sort |
experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study |
publisher |
BMC |
series |
Orphanet Journal of Rare Diseases |
issn |
1750-1172 |
publishDate |
2020-07-01 |
description |
Abstract Background Expanded access programs (EAPs) allow patients with serious, life-threatening conditions access to drugs prior to their formal approval. Despite the possible benefits for patients, EAPs present several challenges, including uncertainty regarding a drug’s efficacy and safety as well as inequities regarding access to treatment. Although the number of EAPs is growing, the experience of patients participating in EAPs has not yet been studied. In Germany, an EAP for the treatment of Spinal Muscular Atrophy (SMA) with nusinersen ran from December 2016 to May 2017). SMA is a rare, progressive neuromuscular disorder characterized by muscle atrophy and proximal muscle weakness. Insights into patients’ and caregivers’ experiences could help to improve future EAPs. Results We conducted a prospective study using semi-structured interviews with caregivers of children with Spinal Muscular Atrophy (SMA) Type 1who participated in the nusinersen EAP in Germany. Interviews were transcribed verbatim and analyzed using an inductive approach according to the principles of content analysis. Eight families participated in the study. Their children were between 2 and 28 months old. Six children received non-invasive ventilation. Participation in the EAP marked an important turning point in the caregivers’ experiences. Their perspective changed from a severely limited life expectancy and a palliative approach to a more optimistic view including hopes for a longer life and positive development of their children. However, participating in the EAP was also challenging for caregivers in several ways. Lack of information regarding the launch of the program and the enrollment procedures caused significant uncertainty and stress among caregivers prior to the actual treatment. Further, concerns persisted that nusinersen could not be approved or that the child could be excluded due to an insufficient treatment response. Good communication and trusting relationships with medical and non-medical staff at the hospital helped caregivers cope with the uncertainties associated with the treatment. Conclusion From the caregivers’ perspective, there was no alternative to participating in the EAP for nusinersen. All participants were positive regarding their decision to participate. However, this study suggests that developing procedures to increase speed and transparency and to ensure fairness could help to further improve the system of EAPs as a way to provide urgently needed care to highly vulnerable patients. |
topic |
Spinal muscular atrophy Nusinersen Expanded Access program Compassionate care program Qualitative research Interview study |
url |
http://link.springer.com/article/10.1186/s13023-020-01477-7 |
work_keys_str_mv |
AT petrakiefer experiencesofcaregiversofchildrenwithspinalmuscularatrophyparticipatingintheexpandedaccessprogramfornusinersenalongitudinalqualitativestudy AT janberndkirschner experiencesofcaregiversofchildrenwithspinalmuscularatrophyparticipatingintheexpandedaccessprogramfornusinersenalongitudinalqualitativestudy AT astridpechmann experiencesofcaregiversofchildrenwithspinalmuscularatrophyparticipatingintheexpandedaccessprogramfornusinersenalongitudinalqualitativestudy AT thorstenlanger experiencesofcaregiversofchildrenwithspinalmuscularatrophyparticipatingintheexpandedaccessprogramfornusinersenalongitudinalqualitativestudy |
_version_ |
1724625707883036672 |